secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001213900-25-100985
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex gets 180-day Nasdaq extension to April 20, 2026 for bid price compliance
--------------------------------------------------------------------------------

- Nasdaq granted Incannex until April 20, 2026 to maintain $1.00 closing bid for 10 consecutive days.
- Extension follows Incannex meeting all other listing criteria and providing reverse stock split intent.
- CEO notes two Phase 2 clinical data packages delivered in 2025 and strong cash position.
- Company will monitor share price and take actions to regain compliance within the extension period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/0001213900-25-100985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390025100985/ea0262073-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-100985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer